Clinical Updates in Treating Advanced Prostate Cancer - Episode 8

ARPI-Based Combination Regimens – ARANOTE (Darolutamide and ADT)

,

Panelists discuss how the ARANOTE trial exploring darolutamide in combination with androgen deprivation therapy shows potential benefits in managing advanced prostate cancer.

What are your impressions of the ARANOTE trial?